Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia
Miriam Frech,
Lutz B. Jehn,
Kathleen Stabla,
Stephan Mielke,
Björn Steffen,
Hermann Einsele,
Stephan K. Metzelder,
Andreas Neubauer
Affiliations
Miriam Frech
Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany
Lutz B. Jehn
Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany
Kathleen Stabla
Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany
Stephan Mielke
Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Straβe 6, Germany
Björn Steffen
Department of Medicine, Hematology/Oncology, Goethe University of Frankfurt, Theodor-Stern-Kai 7, Germany
Hermann Einsele
Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Straβe 6, Germany
Stephan K. Metzelder
Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany
Andreas Neubauer
Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany
